Novacta therapeutics and Oxygen Healthcare announce a multi FTE medicinal chemistry collaboration
“Following two very successful projects, we are excited to enter a third collaboration that combines the strengths of both companies.” said Dr. Sjoerd Wadman, Head of Chemistry at Novacta Therapeutics.
Sunil Shah, CEO of O2h said “We are excited to be a part of and support the research programs that Novacta is pioneering in the area of Lantibiotics and Bacteriocins. The large investment that they have received to date is testament to the scientific breakthroughs that they have made in this area”.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.